PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

BACKGROUND: Oncogenic mutations of PIK3CA, RAS (KRAS, NRAS), and BRAF have been identified in various malignancies, and activate the PI3K/AKT/mTOR and RAS/RAF/MEK pathways, respectively. Both pathways are critical drivers of tumorigenesis. METHODS: Tumor tissues from 504 patients with diverse cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Janku, Filip, Lee, J. Jack, Tsimberidou, Apostolia M., Hong, David S., Naing, Aung, Falchook, Gerald S., Fu, Siqing, Luthra, Rajyalakshmi, Garrido-Laguna, Ignacio, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146490/
https://www.ncbi.nlm.nih.gov/pubmed/21829508
http://dx.doi.org/10.1371/journal.pone.0022769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146490/
https://www.ncbi.nlm.nih.gov/pubmed/21829508
http://dx.doi.org/10.1371/journal.pone.0022769

Ejemplares similares